<--- Back to Details
First PageDocument Content
Biotechnology / Biology / Nature / Experimental cancer treatments / Versant / Oncolytic virus / Biopharmaceutical
Date: 2016-01-27 13:02:32
Biotechnology
Biology
Nature
Experimental cancer treatments
Versant
Oncolytic virus
Biopharmaceutical

FOR  IMMEDIATE  RELEASE        

Add to Reading List

Source URL: www.versantventures.com

Download Document from Source Website

File Size: 82,52 KB

Share Document on Facebook

Similar Documents

INDUSTRY ISSUES What Is a Biopharmaceutical?

DocID: 1v8Wa - View Document

Curtana Pharmaceuticals Selected to Present at Inaugural University Startups Demo Day in Washington, DC AUSTIN, TX – September 7, 2016 – Curtana Pharmaceuticals, a privately-held, preclinical stage biopharmaceutical

DocID: 1v7ko - View Document

INDUSTRY ISSUES What Is a Biopharmaceutical?

DocID: 1v72B - View Document

Beyond Operational Excellence through Digital Continuity Sustainable Health for Biopharmaceutical Manufacturing by Julie Fraser and Amy Rowell

DocID: 1v5W2 - View Document

TERMINOLOGY What is a Biopharmaceutical?

DocID: 1v5mX - View Document